BioBridgeXAll companies

Marker Therapeutics, Inc.

Pharmaceutical company · Houston, Texas, United States · Nasdaq: MRKR

Marker Therapeutics, Inc. is a pharmaceutical company headquartered in Houston, Texas, United States. Its shares trade on Nasdaq under the ticker MRKR. It has received 4 US government small-business research awards (SBIR/STTR) from health agencies, $6.7 million in total, most recently in 2024. It has reported private securities offerings to the US SEC, most recently $16 million sold in a notice filed in 2024.

www.markertherapeutics.comProfile compiled from public records. Is this your company? Request a correction or update

Marker Therapeutics at a glance

Typepharmaceutical company
HeadquartersHouston, Texas, United States
Stock listingNasdaq: MRKR
SEC industryPharmaceutical Preparations
Employees (per SBIR records)45
SEC CIK1094038

What does Marker Therapeutics do?

US government research funding

4 SBIR/STTR small-business research awards from US health agencies, $6.7 million in total (2023 to 2024). NIH funding came from the National Cancer Institute.

Private fundraising reported to the SEC

10 Form D notices; the most recent reported $16.1 million sold (2024).

Frequently asked questions about Marker Therapeutics

Where is Marker Therapeutics headquartered?

Marker Therapeutics, Inc. is headquartered in Houston, Texas, United States.

What does Marker Therapeutics do?

Marker Therapeutics, Inc. is a pharmaceutical company. Its SEC industry classification is Pharmaceutical Preparations.

Is Marker Therapeutics a public company?

Yes. Marker Therapeutics, Inc. trades on Nasdaq under the ticker MRKR.

Similar companies

Need a CRO or CDMO for your next study?

Compare transparent quotes from research and manufacturing partners, then contract once. Free for buyers.

Compare quotes

Sources

Location data: GeoNames (geonames.org), CC BY 4.0.

Last updated 2026-09-23.